DeepScribe, the ambient AI of choice for specialty care, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, announced a partnership that brings DeepScribe’s AI documentation to clinicians using Flatiron’s OncoEMR, a leading cloud based electronic medical record platform.
The partnership establishes DeepScribe as the first ambient AI solution partner for Flatiron Health.
By integrating DeepScribe’s oncology-specific AI with OncoEMR, over 4,200 providers across more than 800 community-based cancer care locations across the U.S. in Flatiron’s network can significantly reduce the time they spend charting and cultivate a more personal connection with patients. In recent feedback from oncologists, 91% called DeepScribe easy to use, with adoption rates over 80% within large oncology groups.
“We are thrilled to partner with Flatiron and help them continue having a meaningful impact on cancer care,” said Matthew Ko, DeepScribe CEO and Co-founder. “We want to ensure that their clinicians can make the most of every encounter, with the information and time they need to truly connect with the patient. The seamless integration with OncoEMR helps make that happen.”
Health Technology Insights: Apps Associates Launches AppsAccelerate to Boost Healthcare Operations & Insights
This partnership will build on traction solidifying DeepScribe as a favored ambient AI scribe for oncology, with nearly 1,000 oncologists trusting the platform each day for care documentation.
“Technology—including AI tools—are transforming the point of care, improving outcomes for both patients and the clinicians who serve them,” said Nina Chavez, VP of Strategic Partnerships and Alliances, Flatiron Health. “We’re excited to bring DeepScribe’s AI documentation tools to our network of providers, reducing the administrative burden on providers and enabling more meaningful time with patients.”
DeepScribe’s ambient AI is optimized for oncology by understanding the workflow, terminology, and subtleties of cancer care, automatically creating a structured clinical note. This includes intelligently pulling in key contextual information from previous visits, understanding interval history based on the current conversation, and organizing the note’s plan with relevant ICD-10 diagnosis codes.
Health Technology Insights: Sonde Health Brings Voice-Based Health Monitoring to Qualcomm’s Snapdragon S7+ Gen 1
Each AI-generated note automatically populates the patient chart within OncoEMR for clinician review and signoff, streamlining the workflow even further and giving clinicians more time in their day—and more time for care.
“Oncology care involves complex decision-making and information management,” said Dean Dalili, MD, MHCM, DeepScribe Chief Medical Officer. “Our teams have worked closely with oncologists for our AI to capture the nuances and details of a cancer care conversation. Oncologists tell us how well DeepScribe captures terminology, medication names, care plan details. We look forward to each Flatiron clinician benefitting—and in turn, each of their patients benefitting.”
Health Technology Insights: HeartX Cardiovascular Accelerator Seeks Early-Stage Innovators for 2025
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
